Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome

Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome

<p>Abstract</p> <p>Background</p> <p>Controlled trials have found therapeutic plasma exchange (TPE) and intravenous immunoglobulin (IVIg) infusion therapy to be equally efficacious in treating Guillain-Barré syndrome (GBS). Due to increases in the price of IVIg compared...

Full description

Bibliographic Details
Main Authors: Chainani Ashok, Hazard Elisabeth, Brown David, Winters Jeffrey L, Andrzejewski Chester
Format: Article
Language:English
Published: BMC 2011-05-01
Series:BMC Health Services Research
Subjects:
plasma exchange
intravenous immunoglobulin
Guillain-Barré syndrome
cost effectiveness
Online Access:http://www.biomedcentral.com/1472-6963/11/101

Internet

http://www.biomedcentral.com/1472-6963/11/101

Similar Items